Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
ALTH similar filings
- 18 May 10 Allos Therapeutics’ Pralatrexate Granted FDA Orphan Drug Designation for the Treatment of Bladder Cancer
- 5 May 10 Allos Therapeutics Reports First Quarter 2010 Financial Results
- 27 Apr 10 Allos Therapeutics Appoints Dr. Charles Morris as Chief Medical Officer
- 9 Apr 10 Changes in Registrant's Certifying Accountant
- 1 Mar 10 Allos Therapeutics Reports Fourth Quarter and Full Year 2009 Financial Results
- 26 Feb 10 Departure of Directors or Certain Officers
- 29 Jan 10 Departure of Directors or Certain Officers
Filing view
External links